PPP2R1A and epilepsy: Clinically, pathogenic variants in PPP2R1A (encoding PP2A-A) and PPP2R5D (encoding PP2A-B) have been linked to NDDs characterized by severe intellectual disability, speech impairment, epilepsy, and developmental delay (5–9).